Roivant Sciences is a leading biopharmaceutical company that is dedicated to developing groundbreaking medicines and technologies. They achieve this by creating agile and focused companies known as Vants. With over 20 portfolio companies, Roivant has conducted 10 successful Phase 3 trials since 2019.

In fact, they recently launched VTAMA® (tapinarof) cream, 1%, which is a topical treatment for plaque psoriasis in adults. As an organization, Roivant prides itself on its diverse leadership and employee base, as well as its inclusive culture. They have worked hard to build a team that reflects these values.

Additionally, Roivant has a robust pipeline of investigational drugs across their family of companies, with 6 FDA approvals to date. If you are interested in joining a company that is revolutionizing healthcare, Roivant offers exciting career opportunities. Contact them today and be a part of the future of medicine